Had filed an ANDA for Wellbutrin xl 150 mg a generic formulation of Wellbutrin XL(R).
Biovail also filed suit in the United States District Court For The Southern District of Florida against Abrika Pharmaceuticals LLLP, which has submitted an ANDA for a generic 150mg version Wellbutrin xl 150 mg of Wellbutrin XL(R). Biovail Corporation undertakes Wellbutrin xl 150 mg no obligation to update or revise any forward-looking statement. HAYWARD, Calif. Forward-looking statements are identified by words such as "believe", "anticipate", "expect", "intend", "plan", "will", "may" and other similar expressions. Under the terms of the agreement, Biovail manufactures and supplies all of GSK's trade and sample supply requirements. "We are confident in the strength of our intellectual property rights as they relate to Wellbutrin XL(R), and will defend these vigorously," said Dr. About Andrx Corporation We are a pharmaceutical company that: --develops, manufactures and commercializes generic versions of controlled-release, niche and immediate-release pharmaceutical products, including oral contraceptives; --distributes pharmaceutical products, primarily generics, which have been commercialized by others, as well as our own, primarily to independent pharmacies, pharmacy chains and physicians' offices; and --develops and manufactures pharmaceutical products for other pharmaceutical companies, including combination products and controlled-release formulations utilizing our patented technologies and formulation capabilities. Forward-looking statements include, but are not necessarily limited to, risks and uncertainties, wellbutrin xl 150 mg including the difficulty of predicting U.
We have based these forward-looking statements on our current expectations and projections about future events. At the present time, it is not known if the ANDA submission has been accepted for review by the FDA. GlaxoSmithKline markets Wellbutrin XL and wellbutrin xl 150 mg for the treatment of depression. Biovail's supply price is based on a percentage of the GSK's net sales of Wellbutrin XL(R), with the price escalating as certain annual net sales thresholds are met.
Wellbutrin xl 150 mg according to NDCHealth, U. For more information about wellbutrin xl 150 mg biovail, visit the company's Web site at www.Com For further information, please contact Ken Howling at 905-286-3000 or send inquiries to ir@biovail. Forward-looking statements (statements which are not historical facts) in this release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Biovail filed suit in the United States District Court wellbutrin xl 150 mg for the Central District of California against Anchen Pharmaceuticals Inc. , which has submitted wellbutrin xl 150 mg an ANDA for generic 150mg and 300mg versions of Wellbutrin XL(R). In accordance with the relevant regulations, Biovail has a 45-day period in which to analyze the submission and determine if the intellectual property protecting Wellbutrin XL(R) has been infringed. Biovail is responsible Wellbutrin xl 150 mg for the costs to manufacture the product. The hospital pharmacists weren't aware of the XL formulation, which was new at the time, and XL wasn't clearly written in the order. In another case, a prescriber ordered Wellbutrin XR, 150 mg daily, although no such product exists. In addition, Wellbutrin xl 150 mg any statements that refer to expectations, projections or other characterizations of future events or circumstances are forward-looking statements.
grace | Monday 12th October 2009 01:13:17 PM
Imbalances in these brain chemicals are associated with depressed mood and other symptoms of depression.
adam | Thursday 22nd October 2009 12:14:30 AM
Biovail continues to develop a Wellbutrin xl 150 mg new once-daily bupropion formulation.jeeplover | Tuesday 13th October 2009 02:55:43 PM
Is a technology based specialty pharmaceutical company applying its formulation wellbutrin xl 150 mg expertise and drug delivery technology to the development of controlled-release and specialty generics in addition to the development of branded products.
laba | Wednesday 14th October 2009 02:34:48 PM
These two formulation patents are valid until 2018.
steven | Thursday 1st October 2009 04:00:30 PM
If a legal patent wellbutrin xl 150 mg infringement suit is commenced within 45 days from receipt of the Notice of Non-Infringement, pursuant to the provisions of the Hatch-Waxman legislation, the FDA cannot approve the generic product for up to a period of 30 months or upon a Court decision of non-infringement -- whichever is earlier.
hiroki | Saturday 10th October 2009 11:15:59 AM
The patent estate protecting Wellbutrin XL(R) consists of Wellbutrin xl 150 mg two formulation patents (U.